ID: ALA515570

Max Phase: Preclinical

Molecular Formula: C20H21N7O4

Molecular Weight: 423.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ncnc2c1nc(NCc1ccc3ncccc3c1)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C20H21N7O4/c21-17-14-18(25-9-24-17)27(19-16(30)15(29)13(8-28)31-19)20(26-14)23-7-10-3-4-12-11(6-10)2-1-5-22-12/h1-6,9,13,15-16,19,28-30H,7-8H2,(H,23,26)(H2,21,24,25)/t13-,15-,16-,19-/m1/s1

Standard InChI Key:  ZPAVHMFARWZWPX-NVQRDWNXSA-N

Associated Targets(Human)

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

78 kDa glucose-regulated protein 3319 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Heat shock cognate 71 kDa protein 193 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 423.43Molecular Weight (Monoisotopic): 423.1655AlogP: 0.18#Rotatable Bonds: 5
Polar Surface Area: 164.46Molecular Species: NEUTRALHBA: 11HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.45CX Basic pKa: 4.77CX LogP: -0.05CX LogD: -0.05
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.30Np Likeness Score: -0.04

References

1. Williamson DS, Borgognoni J, Clay A, Daniels Z, Dokurno P, Drysdale MJ, Foloppe N, Francis GL, Graham CJ, Howes R, Macias AT, Murray JB, Parsons R, Shaw T, Surgenor AE, Terry L, Wang Y, Wood M, Massey AJ..  (2009)  Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design.,  52  (6): [PMID:19256508] [10.1021/jm801627a]
2. Macias AT, Williamson DS, Allen N, Borgognoni J, Clay A, Daniels Z, Dokurno P, Drysdale MJ, Francis GL, Graham CJ, Howes R, Matassova N, Murray JB, Parsons R, Shaw T, Surgenor AE, Terry L, Wang Y, Wood M, Massey AJ..  (2011)  Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivity.,  54  (12): [PMID:21526763] [10.1021/jm101625x]
3. Cheeseman MD, Westwood IM, Barbeau O, Rowlands M, Dobson S, Jones AM, Jeganathan F, Burke R, Kadi N, Workman P, Collins I, van Montfort RL, Jones K..  (2016)  Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70.,  59  (10): [PMID:27119979] [10.1021/acs.jmedchem.5b02001]

Source